SCHEMBL8868634

SCHEMBL8868634

CCCCNC(=O)c1ccc(S(=O)(=O)NC(=O)c2ccc(C(=O)NCC(=O)OC)nc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 4/20 0.51
EGFR P00533 3/20 0.44
CA2 P00918 2/20 0.44
CYP2C9 P11712 2/20 0.42
ALDH1A1 P00352 2/20 0.42
LMNA P02545 1/20 0.42
ALB P02768 1/20 0.42
TSHR P16473 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
EGLN1 Q9GZT9 1/20 0.42
KMT2A Q03164 2/20 0.41
FLT1 P17948 1/20 0.40
FLT4 P35916 1/20 0.40
KDR P35968 1/20 0.40
KDM4E B2RXH2 1/20 0.40
MMP1 P03956 1/20 0.39
BCL2L1 Q07817 1/20 0.39
MCL1 Q07820 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8868794 0.96 CA2 (0.50) P4HTMEGFRCA2ALDH1A1KMT2A
SCHEMBL8868007 0.92 P4HTM (0.47) P4HTMEGFRCA2CYP2C9ALDH1A1
SCHEMBL8869147 0.92 P4HTM (0.46) P4HTMEGFRCA2CYP2C9ALDH1A1
SCHEMBL8868459 0.91 HPGD (0.48) P4HTMEGFRALDH1A1LMNAEGLN1
SCHEMBL8869152 0.91 EGLN1 (0.54) P4HTMEGFRCA2CYP2C9ALDH1A1
SCHEMBL8869116 0.90 P4HTM (0.53) P4HTMEGFRCA2CYP2C9ALDH1A1
SCHEMBL8869204 0.90 P4HTM (0.53) P4HTMEGFRALDH1A1TSHRKMT2A
SCHEMBL8869765 0.90 P4HTM (0.51) P4HTMEGFRCA2CYP2C9ALDH1A1
SCHEMBL8869167 0.90 P4HTM (0.54) P4HTMEGFRTSHRKMT2AFLT1
SCHEMBL8869570 0.90 SMN1; SMN2 (0.46) P4HTMTDP1EGLN1KMT2ABCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed